Form 4 for NOC Northrop Grumman
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-11 · accession 0001628280-26-008125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-11 | NOC | Warden Kathy J | COB, CEO, Pres, Dir | M - OptEx | $0.00 | +34.5K | 206.1K | +20% | $0 |
| D | 2026-02-13 | 2026-02-11 | NOC | Warden Kathy J | COB, CEO, Pres, Dir | F - Tax | $678.83 | -15.4K | 190.8K | -7% | -$10.43M |
| DM | 2026-02-13 | 2026-02-11 | NOC | Warden Kathy J | COB, CEO, Pres, Dir | A - Grant | $0.00 | +36.9K | 41.8K | +756% | $0 |
| D | 2026-02-13 | 2026-02-11 | NOC | Warden Kathy J | COB, CEO, Pres, Dir | M - OptEx | $0.00 | -34.5K | 67.5K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-11 | M | A | 34,546.16 | $0.00 | 206,148.56 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-11 | F | D | 15,371 | $678.83 | 190,777.56 | D | — | — | |
| 3 | Derivative | Restricted Performance Stock Rights | 2026-02-11 | A | A | 28,785.16 | $0.00 | 102,064.16 | D | — · — to — | 28,785.16 Common Stock | (F2) The RPSRs acquired include (i) 11,204.16 vested RPSRs with respect to the measurement period ended 12/31/25 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/16/23 that resulted in settlement at 148% of the target award; and (ii) 17,581 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/11/26 with a measurement period ending on 12/31/28. A total of 34,546.16 shares were issued in settlement of the 2023 RPSRs with a measurement period that ended 12/31/25, and the target award amount of 23,342 RPSRs was previously reported in connection with the grant of the 2023 RPSRs. (F3) Total amount includes (i) 34,546.16 vested RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ended on 12/31/25; (ii) 24,309 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iii) 25,628 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27; and (iv) 17,581 RPSRs granted under the 2024 LTISP on 2/11/26 with a measurement period ending on 12/31/28. (F1) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |
| 4 | Derivative | Restricted Stock Rights | 2026-02-11 | A | A | 8,113 | $0.00 | 41,780 | D | — · — to — | 8,113 Common Stock | (F6) Total amount includes (i) 10,760 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (ii) 11,155 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (iii) 11,752 RSRs granted under the 2024 LTISP on 2/18/25 that will vest on 2/18/28; and (iv) 8,113 RSRs granted under 2024 LTISP on 2/11/26 that will vest on 2/12/29. (F4) Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. (F5) The RSRs were granted under the 2024 LTISP on 2/11/26 and will vest on 2/12/29. |
| 5 | Derivative | Restricted Performance Stock Rights | 2026-02-11 | M | D | 34,546.16 | $0.00 | 67,518 | D | — · — to — | 34,546.16 Common Stock | (F7) Total amount includes (i) 24,309 RPSRs granted under the 2011 LTISP on 2/16/24 with a measurement period ending on 12/31/26; (ii) 25,628 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27; and (iii) 17,581 RPSRs granted under the 2024 LTISP on 2/11/26 with a measurement period ending 12/31/28. (F1) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |